Stay updated on Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial page.

Latest updates to the Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry (v3.4.2) is added to the history, and the previous funding notice and earlier revision entry (v3.4.1) are removed as part of an administrative update.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page version to v3.4.1, removing the previous v3.4.0 tag.SummaryDifference0.8%

- Check28 days agoChange DetectedThe history view now includes a glossary toggle and green/red highlights to indicate additions and deletions; the revision label was updated to v3.4.0 and the No FEAR Act wording was adjusted.SummaryDifference1.0%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added to the Study Record Versions, and v3.3.3 was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe Study Record Versions now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link as well as Revision: v3.3.2 were removed from the footer.SummaryDifference0.2%

- Check85 days agoChange DetectedThe history now shows a new revision entry (v3.3.2) and the removal of the previous revision entry (v3.3.1) as part of page version updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Botensilimab and Balstilimab in Colorectal Cancer Clinical Trial page.